Upgrade

Theriva Biologics, Inc.

TOVX

Last
$0.22
Day
-4.4%
1y
-53.6%
5y
-99.1%
52w
-73.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1132d
EMA 21
0.23
EMA 50
0.23
EMA 200
0.33
20d high
-8.0%
5y high
-99.3%
5y range
0th
Website · 15 employees · United States

Positions held

Your positions

TOVX isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
2
Hold
watch
Signal
Neutral
Target
$0.25
Stop
$0.21
Stop distance
3.2%
Target vs last
+15.2%

Fundamentals

Market cap$10.42MEnterprise value$2.64MTrailing P/E0.30Forward P/E-1.14
PEG—Price / book0.85Beta1.19Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin100.0%Operating margin-40.2%
Profit margin0.0%ROE-101.9%ROA-21.3%Debt / equity0.29
Current ratio1.13Free cash flow-$6.69MAnalyst recommendationnoneMean target$2.50
52w high$0.8652w low$0.16

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.3M$0.0M$0.0M$0.0M—
Op margin—-709.0%————
Net income-$3.2M-$2.0M-$2.0M-$4.4M-$13.1M—
Gross margin——————
Gross profit——————
Operating income-$3.3M-$2.1M-$2.1M-$4.4M-$13.1M—
  • Revenue -100% vs prior quarter ($0 vs $0.3M).

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$0.0M$0.0M—
Op margin—————
Net income-$23.7M-$25.7M-$18.3M-$19.7M—
Gross margin—————
Gross profit—————
Operating income-$24.1M-$19.4M-$21.4M-$21.6M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

TOVX · daily-1.6% over 13 sessions
Close EMA21 EMA50 EMA200
0.210.220.230.240.252026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$13M-$10M-$6M-$3M$0M-709%-350%10%2025-Q22025-Q32025-Q42026-Q12026-Q2